@article{OttoFriedrichMadunićetal.2020, author = {Otto, Christoph and Friedrich, Alexandra and Madunić, Ivana Vrhovac and Baumeier, Christian and Schwenk, Robert W. and Karaica, Dean and Germer, Christoph-Thomas and Sch{\"u}rmann, Annette and Sabolić, Ivan and Koepsell, Hermann, Hermann}, title = {Antidiabetic Effects of a Tripeptide That Decreases Abundance of Na\(^+\)-D-glucose Cotransporter SGLT1 in the Brush-Border Membrane of the Small Intestine}, series = {ACS Omega}, volume = {5}, journal = {ACS Omega}, number = {45}, doi = {10.1021/acsomega.0c03844}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-230654}, pages = {29127-29139}, year = {2020}, abstract = {In enterocytes, protein RS1 (RSC1A1) mediates an increase of glucose absorption after ingestion of glucose-rich food via upregulation of Na+-D-glucose cotransporter SGLT1 in the brush-border membrane (BBM). Whereas RS1 decelerates the exocytotic pathway of vesicles containing SGLT1 at low glucose levels between meals, RS1-mediated deceleration is relieved after ingestion of glucose-rich food. Regulation of SGLT1 is mediated by RS1 domain RS1-Reg, in which Gln-Ser-Pro (QSP) is effective. In contrast to QSP and RS1-Reg, Gln-Glu-Pro (QEP) and RS1-Reg with a serine to glutamate exchange in the QSP motif downregulate the abundance of SGLT1 in the BBM at high intracellular glucose concentrations by about 50\%. We investigated whether oral application of QEP improves diabetes in db/db mice and affects the induction of diabetes in New Zealand obese (NZO) mice under glucolipotoxic conditions. After 6-day administration of drinking water containing 5 mM QEP to db/db mice, fasting glucose was decreased, increase of blood glucose in the oral glucose tolerance test was blunted, and insulin sensitivity was increased. When QEP was added for several days to a high fat/high carbohydrate diet that induced diabetes in NZO mice, the increase of random plasma glucose was prevented, accompanied by lower plasma insulin levels. QEP is considered a lead compound for development of new antidiabetic drugs with more rapid cellular uptake. In contrast to SGLT1 inhibitors, QEP-based drugs may be applied in combination with insulin for the treatment of type 1 and type 2 diabetes, decreasing the required insulin amount, and thereby may reduce the risk of hypoglycemia.}, language = {en} } @article{HanftLichtenberg2020, author = {Hanft, Anna and Lichtenberg, Crispin}, title = {Dimerization of 2-[(2-((2-aminophenyl)thio)phenyl)amino]-cyclohepta-2,4,6-trien-1-one through hydrogen bonding, C\(_{19}\)H\(_{16}\)N\(_2\)OS}, series = {Zeitschrift f{\"u}r Kristallographie - New Crystal Structures}, volume = {235}, journal = {Zeitschrift f{\"u}r Kristallographie - New Crystal Structures}, number = {4}, doi = {10.1515/ncrs-2020-0124}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-229482}, pages = {963-966}, year = {2020}, abstract = {C\(_{19}\)H\(_{16}\)N\(_2\)OS, triclinic, P (1) over bar (no. 2), a= 8.1510(3) angstrom, b = 8.8021(3) angstrom, c =11.3953(5) angstrom, alpha =72.546(2)degrees, beta=84.568(2)degrees, gamma =80.760(2)degrees, V =768.86(5) angstrom(3), Z =2, R\(_{gt}\)(F) = 0.0491, WR\(_{ref}\)(F-2) = 0.1494, T =100 K.}, language = {en} } @article{WirthensohnFinze2020, author = {Wirthensohn, Raphael and Finze, Maik}, title = {The crystal structure of trimethylsulfonium tris(trifluoromethylsulfonyl)methanide, C\(_7\)H\(_9\)F\(_9\)O\(_6\)S\(_4\)}, series = {Zeitschrift f{\"u}r Kristallographie - New Crystal Structures}, volume = {236}, journal = {Zeitschrift f{\"u}r Kristallographie - New Crystal Structures}, number = {2}, doi = {10.1515/ncrs-2020-0612}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-231358}, pages = {417-419}, year = {2020}, abstract = {C\(_7\)H\(_9\)F\(_9\)O\(_6\)S\(_4\), orthorhombic, P2\(_1\)2\(_1\)2\(_1\) (no. 19), a = 8.80180(10) {\AA}, b= 10.96580(10) {\AA}, c = 16.91360(10) {\AA},V= 1632.48(3) {\AA}\(^3\), Z= 4, R\(_{gt}\)(F) = 0.0222, wR\(_{ref}\)(F\(^2\)) = 0.0604, T = 100 K.}, language = {en} }